Investor Alert

Aug. 7, 2020, 2:04 p.m. EDT

Tissue Plasminogen Activator Market to Witness Robust Expansion by 2026 – Bayer AG, Genentech, Sigma-Aldrich, Taj Pharmaceuticals

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Aug 07, 2020 (Market Insight Reports) -- The global Tissue Plasminogen Activator market report is a comprehensive research that focuses on the overall consumption structure, Demand, Revenue and Forecast till 2026. The report focuses on key companies in the global Tissue Plasminogen Activator industry, market segments, competition, and the growth drivers, constraints and SWOT analysis. This report focuses on Tissue Plasminogen Activator volume and value at the global level, regional level and company level.

Request for sample:


Tissue plasminogen activator (tPA) is an enzyme associated with breakdown of blood clots (fibrinolysis). It is a serine protease present in endothelial cells. Conversion of plasminogen to plasmin is catalyzed with the help of serine protease. Serine protease is a major enzyme for clot breakdown.

Tissue plasminogen activator (tPA) is also produced by using recombinant technology techniques known as recombinant tissue plasminogen activator (rtPA). Specific rtPAs are alteplase, tenecteplase, and reteplase

The Report includes top leading companies Bayer AG, Genentech, Sigma-Aldrich, Taj Pharmaceuticals, Zydus Cadila Healthcare (nse:CADILAHC), Calbiochem

Global Tissue Plasminogen Activator Market, By Type

Active tPA
tPA Complexed with Inhibitor Type 1 (PAI-1)
tPA Complexed with C1-inhibitor

Global Tissue Plasminogen Activator Market, By Application

Ischemic Stroke
Pulmonary Embolism
Myocardial Infarction

Global Tissue Plasminogen Activator Market Segmentation by Region :

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Russia, Rest of Europe, Central & South America

Table of Contents:

Report Overview: It includes Tissue Plasminogen Activator market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Tissue Plasminogen Activator market trends and shares market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Tissue Plasminogen Activator market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Tissue Plasminogen Activator market report is studied on the basis of the market size by application, the market size by product, key players, and market forecast.

Key Players: This part of the Tissue Plasminogen Activator market report discusses expansion plans of companies, key mergers and acquisitions, funding and investment analysis, company establishment dates, revenues of manufacturers, and their areas served and manufacturing bases.

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.